EUVIMEDEUVIMED entdecken
Crossref

Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway

Shuyuan Zhu, Shuai Wang, Tao Luo

Archives of Biochemistry and Biophysics · 2023

DOI: 10.1016/j.abb.2023.109689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023. Verfasst von Shuyuan Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defective autophagy-induced intracellular lipid degradation is causally associated with non-alcoholic fatty liver disease (NAFLD) development. Therefore, agents that can restore autophagy may have potential clinical application prospects on this public health issue. Galanin (GAL) is a pleiotropic peptide that regulates autophagy and is a potential drug for the treatment of NAFLD. In this study, we used an MCD-induced NAFLD mouse model in vivo and an FFA-induced HepG2 hepatocyte model in vitro to evaluate the anti-NAFLD effect of GAL. Exogenous GAL supplementation significantly attenuated lipid droplet accumulation and suppressed hepatocyte TG levels in mice and cell models. Mechanistically, Galanin-mediated reduction of lipid accumulation was positively correlated with upregulated p-AMPK, as evidenced by upregulated protein expressions of fatty acid oxidation-related gene markers (PPAR-α and CPT1A), upregulated expressions of the autophagy-related marker (LC3B), and downregulated autophagic substrate p62 levels. In FFA-treated HepG2 cells, activation of fatty acid oxidation and autophagy-related proteins by galanin was reversed by autophagy inhibitors, chloroquine, and the AMPK inhibitor. Galanin ameliorates hepatic fat accumulation by inducing autophagy and fatty acid oxidation via the AMPK/mTOR pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesNon-alcoholic Fatty Liver DiseaseAnimalsMiceGalaninTOR Serine-Threonine KinasesLiverLipid MetabolismAutophagyFatty AcidsLipidsMice, Inbred C57BLDiet, High-Fat

Stichwörter der Autor:innen

AMPKAutophagyGalaninNAFLDβ-Oxidation

Substanzen

AMP-Activated Protein KinasesGalaninTOR Serine-Threonine KinasesFatty AcidsLipids

Autor:innen und Institutionen

  • Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
  • Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: luotao@hospital.cqmu.edu.cn.

Zitieren

APA

Zhu, S., Wang, S., & Luo, T. (2023). Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2023.109689

Vancouver

Zhu S, Wang S, Luo T. Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway. Archives of Biochemistry and Biophysics. 2023. doi:10.1016/j.abb.2023.109689

BibTeX
@article{Zhu2023,
  author = {Zhu, Shuyuan and Wang, Shuai and Luo, Tao},
  title = {Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2023},
  doi = {10.1016/j.abb.2023.109689}
}
Kostenlos starten →